BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 48 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $22,061,000 | +813.9% | 21,425,000 | +838.5% | 0.01% | +500.0% |
| Q2 2018 | $2,414,000 | -55.2% | 2,283,000 | -56.8% | 0.00% | -50.0% |
| Q1 2018 | $5,385,000 | +128.1% | 5,279,000 | +141.8% | 0.00% | +100.0% |
| Q4 2017 | $2,361,000 | -7.5% | 2,183,000 | -4.6% | 0.00% | 0.0% |
| Q3 2017 | $2,553,000 | -49.2% | 2,288,000 | -49.6% | 0.00% | -50.0% |
| Q2 2017 | $5,029,000 | -40.6% | 4,539,000 | -39.4% | 0.00% | -33.3% |
| Q1 2017 | $8,461,000 | -8.7% | 7,492,000 | -9.6% | 0.00% | 0.0% |
| Q4 2016 | $9,268,000 | +76.8% | 8,289,000 | +89.6% | 0.00% | +50.0% |
| Q3 2016 | $5,243,000 | +37.8% | 4,372,000 | +27.6% | 0.00% | +100.0% |
| Q2 2016 | $3,806,000 | -0.5% | 3,427,000 | +3.8% | 0.00% | -50.0% |
| Q1 2016 | $3,824,000 | -64.5% | 3,303,000 | -60.6% | 0.00% | -50.0% |
| Q4 2015 | $10,775,000 | +179.1% | 8,393,000 | +180.9% | 0.00% | +100.0% |
| Q3 2015 | $3,861,000 | -8.1% | 2,988,000 | +9.7% | 0.00% | 0.0% |
| Q2 2015 | $4,200,000 | -49.0% | 2,725,000 | -50.8% | 0.00% | 0.0% |
| Q1 2015 | $8,242,000 | +4.0% | 5,538,000 | -17.8% | 0.00% | -33.3% |
| Q4 2014 | $7,924,000 | +10.3% | 6,740,000 | -0.6% | 0.00% | 0.0% |
| Q3 2014 | $7,182,000 | +123.0% | 6,783,000 | +117.9% | 0.00% | +200.0% |
| Q2 2014 | $3,220,000 | -5.4% | 3,113,000 | +0.2% | 0.00% | 0.0% |
| Q1 2014 | $3,405,000 | +3.4% | 3,108,000 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $3,292,000 | – | 3,108,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|